May 2021

The Tina Trial: A Phase III randomised placebo-controlled trial of mirtazapine as a pharmacotherapy for methamphetamine “Ice” dependence

Crystalline methamphetamine (“ice”) is a growing concern in Australia. There are no approved medications that can be used to treat dependence on this drug.

Read more
April 2019

The health, social and economic implications of risk-taking in adolescence over the life-course: A data linkage study of the Raine cohort

This research aims to capture a complete picture of the health and social impacts of risky behaviour in adolescence and potential benefits of investment in this age group.

April 2019

Understanding the workforce development needs of the AOD sector

The past few decades have seen substantial changes in the AOD sector that have major implications for the development of a responsive, effective, a

April 2019

Enhancing the capacity of the Aged Care workforce to identify and respond to alcohol and other drug use among older people

The oldest cohort of the Baby Boomer generation is starting to transition into aged care services.

February 2019

Lived experiences of stigma and discrimination among South West Sydney Drug Health Services users: A qualitative study

This research aims to offer nuanced and contextualised insights into lives and settings inflected by stigma, discrimination and exclusion.

February 2019

Alcohol and other drug use and safety critical operations in the Australian rail industry

NCETA is partnering with national and international researchers to undertake the first ever investigation of the link between AOD use and safety ri

February 2019

Examining methamphetamine use in South Australia

NCETA has been commissioned by South Australia Police (SAPOL) to examine potential contributory factors to Adelaide’s apparently high rates of meth

February 2019

Combating escalating harms associated with pharmaceutical opioid use in Australia: The POPPY II study

This project seeks to use linked administrative data to examine the patterns of use of prescribed opioids, quantify the risks of adverse outcomes,

February 2019

An open-label, multicentre, single-arm trial of monthly injections of depot buprenorphine in people with opioid dependence

Retaining patients in buprenorphine treatment is essential in maximising treatment outcomes and minimising mortality risk.

December 2018

Opioid Substitution Therapy in Australia: Past, present, future

While OST has made a significant contribution to reducing drug-related harm in Australia there is a gap in the literature about the history of this contribution.

October 2018

Northern Territory AOD Workforce Development Strategy

NCETA has been commissioned to develop a five year NT-specific AOD WFD Strategic Framework.

Pages